Literature DB >> 9684828

Suprarenal vena caval filter placement: follow-up of four filter types in 22 patients.

W J Matchett1, M P Jones, D R McFarland, E J Ferris.   

Abstract

PURPOSE: To determine if suprarenal placement of inferior vena cava (IVC) filters is associated with renal dysfunction or other complications.
MATERIALS AND METHODS: Case files of all patients with suprarenal vena caval filter placement since 1985 were reviewed for clinical and biochemical evidence of renal dysfunction and renal vein thrombosis. The occurrence of associated complications, including IVC occlusion, filter fracture, device migration, and recurrence of pulmonary embolism was also recorded.
RESULTS: Twenty-two (2.9%) of 764 IVC filters were implanted above the renal veins: titanium Greenfield filter modified hook (TGF-MH) (n = 16), LGM type I (n = 2), LGM type II (n = 2), and Bird's Nest (BN) type I (n = 2). Reasons for suprarenal filter placement included thrombus to the level of the renal veins (n = 9), failure or poor position of the infrarenal filter (n = 6), pregnancy or intent of pregnancy (n = 4), and the malpositioning of BN filters above the renal veins (n = 2). A single patient demonstrated evidence of transient renal dysfunction. Pulmonary embolus was found at autopsy in one patient. Abdominal radiographs were obtained at follow-up of 18 patients and demonstrated a 2 cm or more migration of the filter in five patients (27.7%). This rate of migration was significantly different from the 3% migration rate reported by the authors' institution in the follow-up of 320 infrarenal IVC filters. There was one filter fracture (5.5%.) and penetration of the IVC occurred in one patient (5.5%).
CONCLUSION: Follow-up indicates suprarenal IVC filter placement is safe, and no evidence of permanent renal dysfunction after placement was found. Filter migration was the most frequent complication, but no clinical sequelae were noted with these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9684828     DOI: 10.1016/s1051-0443(98)70327-6

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  8 in total

1.  Complications of inferior vena caval filters.

Authors:  Thuong G Van Ha
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

Review 2.  CT of inferior vena cava filters: normal presentations and potential complications.

Authors:  Nicholas A Georgiou; Douglas S Katz; George Ganson; Kaitlin Eng; Man Hon
Journal:  Emerg Radiol       Date:  2015-07-17

Review 3.  Successful thrombolytic therapy for acute kidney injury secondary to thrombosis of suprarenal inferior vena cava filter.

Authors:  Azra Bihorac; Craig S Kitchens
Journal:  J Thromb Thrombolysis       Date:  2009-11       Impact factor: 2.300

4.  Aspiration thrombectomy in a patient with suprarenal inferior vena cava thrombosis.

Authors:  Hideyuki Kishima; Masashi Fukunaga; Kunihiko Nishian; Ten Saita; Tetsuo Horimatsu; Masataka Sugahara; Takanao Mine; Tohru Masuyama
Journal:  Case Rep Cardiol       Date:  2015-01-27

5.  Caval filters in intensive care: a retrospective study.

Authors:  F Ferraro; T L Di Gennaro; A Torino; J Petruzzi; A d'Elia; P Fusco; R Marfella; B Lettieri
Journal:  Drug Des Devel Ther       Date:  2014-11-06       Impact factor: 4.162

6.  Diagnosis and Management of Spontaneous Lumbar Venous Retroperitoneal Hematoma in Setting of Deep Venous Thrombosis: A Case Report and Algorithm.

Authors:  Joseph Tseng; Michael Leshen; Todd Chapman; Ryan Scott; Olga Kalinkin
Journal:  Case Rep Radiol       Date:  2016-10-03

7.  Endovascular treatment of thrombosed inferior vena cava filters: Techniques and short-term outcomes.

Authors:  Mohammad Arabi; Venkataramu Krishnamurthy; Wojciech Cwikiel; Ranjith Vellody; Thomas W Wakefield; John Rectenwald; David Williams
Journal:  Indian J Radiol Imaging       Date:  2015 Jul-Sep

Review 8.  Retrievable inferior vena cava filters for venous thromboembolism.

Authors:  Han Ni; Lei Lei Win
Journal:  ISRN Radiol       Date:  2013-04-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.